Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in 2012 Leerink Swann Global Health Care Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16, at The Waldorf Astoria...

Key Takeaway: NEW BRUNSWICK, N.J. , Feb. 9, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16 , at The Waldorf Astoria in New York , N.Y. Sheri McCoy , Vice Chairman of the Executive Committee, will

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Feb. 9, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16 , at The Waldorf Astoria in New York , N.Y. Sheri McCoy , Vice Chairman of the Executive Committee, will represent the Company in a session scheduled at 9:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
Last updated: Feb 9, 2012